Midatech Pharma PLC (LON:MTPH), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, has announced the formal opening today of its new headquarters, incorporating purpose built laboratory facilities and offices at 1 Caspian Point in Cardiff, UK.
The Company has moved to the 1 Caspian Point building, part of the Parmer Cardiff campus on the city’s waterfront, where it has created 8,050 sq ft of offices and laboratories on the ground and first floors. This new headquarters provides bespoke accommodation to facilitate the Company’s future plans, particularly with its programmes ustilising its Q-Sphera 3D printing technology to encapsulate medicines in bio-degradable polymers for improved delivery and targeting.
Vaughan Gething MS, Welsh Government Minister for the Economy, when officially opening the new Midatech headquarters said: “Our ambition is for Wales to be a global leader in Life Sciences, whilst stimulating economic growth and creating new high-skilled jobs. We are already able to provide the right environment for companies to innovate and grow and, working alongside the NHS, together we can tackle the greatest healthcare challenges of our generation and address health inequalities. I’m very pleased to see how this business has grown and will play an important part in Wales’ expanding Life Sciences sector.”
Stephen Stamp, Chief Executive Officer of Midatech, said: “Our technology is unique and patented and we have identified a strategy to work on multiple Q-Sphera programmes simultaneously and partner them at an early stage.
“To execute on that plan Midatech needed expanded, purpose-designed labs, as our previous facilities were far from ideal with labs split over two floors and difficulties moving materials and equipment in and out. The new premises at Caspian Point have achieved this without a material increase in our costs and are modern, 50 per cent larger, and much more usable, with a layout tailored to suit our needs exactly, with capacity for further expansion.”
